secwatch / observer

8-K filed May 31, 2024, 7:59 PM ET ticker CDT CIK 0001896212

regulatory confidence high sentiment negative materiality 0.70

Conduit Pharma gets Nasdaq deficiency notice after audit committee director resigns

CDT Equity Inc.

Nasdaq notified Conduit on May 28, 2024 that audit committee now has only two independent directors.
Non-compliance triggered by resignation of director Jennifer McNealey from Board and committees.
Cure period runs until earlier of next annual meeting or May 13, 2025; no immediate delisting.
Company intends to regain compliance by adding a third independent audit committee member.
Common stock (CDT) and warrants (CDTTW) continue trading on Nasdaq during cure period.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-022228
form_type: 8-K
ticker: CDT
cik: 0001896212
company_name: CDT Equity Inc.
filed_at: 2024-05-31T23:59:59+00:00
discovered_at: 2026-05-14T18:03:21.130040+00:00
generated_at: 2026-06-01T07:15:47.074699+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-022228
json_url: https://secwatch.observer/filing/0001493152-24-022228.json
markdown_url: https://secwatch.observer/filing/0001493152-24-022228.md
text_url: https://secwatch.observer/filing/0001493152-24-022228.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/0001493152-24-022228-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

ISPC

iSpecimen flagged for Nasdaq equity shortfall; equity $814K vs $2.5M minimum

iSpecimen Inc. June 1, 2026, 5:00 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

GENC

Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC June 1, 2026, 4:09 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

NUTR

NusaTrip receives Nasdaq delinquency notice for late 10-K and 10-Q; faces delisting if not compliant by Oct 12, 2026

NUSATRIP Inc June 1, 2026, 7:10 AM ET regulatory Items 3.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

XXI

Twenty One Capital receives NYSE non-compliance notice; audit committee lacks independence; cure due June 5

Twenty One Capital, Inc. June 1, 2026, 7:05 AM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

COLA

Columbus Acquisition regains compliance with Nasdaq $50M MVLS rule; delisting risk removed

Columbus Acquisition Corp/Cayman Islands May 29, 2026, 9:56 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

HWH

HWH International receives Nasdaq deficiency notice for equity below $2.5M threshold

HWH International Inc. May 29, 2026, 5:21 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

CSAI

Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing

CLOUDASTRUCTURE, INC. May 29, 2026, 5:09 PM ET regulatory Items 3.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-022228

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.